CELH
Celsius Holdings, Inc.
CELH has a slight edge over TAL overall, supported by stronger valuation and stronger modeled upside.
TAL
TAL Education Group
TAL has slightly lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
TAL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Healthy |
TAL's revenue, profitability, cash flow and balance sheet are all currently healthy.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
TAL PE Valuation
TAL has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
TAL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for TAL, with profitability improving.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the stronger earnings trend. Trailing diluted EPS is up 718% for CELH versus TAL up 302%.
TAL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.86 | +302% |
| Q1 2026 | $2.82 | +129% |
| Q4 2025 | $1.39 | -20% |
| Q3 2025 | $1.03 | -1% |
| Q2 2025 | $1.21 | +59% |
| Q1 2025 | $1.23 | +$1.28 |
| Q4 2024 | $1.73 | +$2.65 |
| Q3 2024 | $1.04 | +$2.33 |
TAL's earnings per share have jumped to their highest in seven years: $4.86 over the past year, up from $1.21 the year before. Its recent earnings include one-off gains.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
TAL has the stronger quarterly revenue trend. Revenue is up 17% for CELH versus up 32% for TAL.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
TAL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $758.4M | +32% |
| Q1 2026 | $808M | +32% |
| Q4 2025 | $770.2M | +27% |
| Q3 2025 | $861.4M | +39% |
| Q2 2025 | $575M | +39% |
| Q1 2025 | $610.2M | +42% |
| Q4 2024 | $606.4M | +62% |
| Q3 2024 | $619.4M | +50% |
TAL's revenue has grown year over year for 13 quarters in a row: $758M last quarter, up 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | +16 points |
| Q1 2026 | 9% | +12 points |
| Q4 2025 | 12% | +15 points |
| Q3 2025 | 11% | +3.5 points |
| Q2 2025 | 2.5% | +6.7 points |
| Q1 2025 | -2.6% | +1.1 points |
| Q4 2024 | -2.9% | +5.8 points |
| Q3 2024 | 7.7% | +0.6 points |
TAL's operating margin was 18% last quarter, up 16 points from the same quarter a year ago, near the top of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
TAL has the stronger cash trend. Its trailing FCF is up 174% versus its history, compared with CELH at up 100%.
TAL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $478.2M | +38% |
| Q1 2026 | -$308.5M | +$29.5M |
| Q4 2025 | $526.7M | +39% |
| Q3 2025 | -$58.1M | -$57.5M |
| Q2 2025 | $347.8M | +41% |
| Q1 2025 | -$338.1M | -$201.6M |
| Q4 2024 | $378M | +53% |
| Q3 2024 | -$576K | +$42.1M |
TAL still generates free cash flow, though less than at its 2019 peak: $638M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
TAL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -317K shares |
| 1 year | -9.1% | -18.6M shares |
| 3 years | +167% | +117M shares |
| 5 years | +163% | +115M shares |
| Available history | +185% | +121M shares |
TAL has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $646.5M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $13.1M |
| Q4 2024 | — |
| Q3 2024 | — |
TAL spent $646M buying back its own shares over the past year, more than ten times what it spent the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
TAL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.7x | Net Cash |
| Q4 2025 | -4.8x | Net Cash |
| Q3 2025 | -4.8x | Net Cash |
| Q2 2025 | -5.9x | Net Cash |
| Q1 2025 | -11.7x | Net Cash |
| Q4 2024 | -10.3x | Net Cash |
| Q3 2024 | -11.5x | Net Cash |
TAL has more cash than debt.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
TAL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.6 | Neutral |
| Stochastic | 7.8 | Oversold |
TAL's weekly RSI is 42 (neutral) and its Stochastic is 8 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
TAL PE vs Consumer Defensive Sector
| Metric | TAL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
TAL has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over TAL on trend strength, trading above more of its moving averages.
TAL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.1 | 11% below |
| 20 week MA | $11.3 | 12% below |
| 50 week MA | $11.1 | 10% below |
| 100 week MA | $11.1 | 10% below |
| 200 week MA | $10.2 | 2.5% below |
TAL is in a downtrend: it's below all five of its weekly moving averages, and 2.5% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
TAL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.4 | $69.7 | +44% |
| 2021 | $69.7 | $4.08 | -94% |
| 2022 | $4.08 | $8.87 | +117% |
| 2023 | $8.87 | $12.6 | +42% |
| 2024 | $12.6 | $9.77 | -23% |
| 2025 | $9.77 | $11.0 | +13% |
| 2026 YTD | $11.0 | $9.95 | -9.5% |
TAL has the edge over CELH on returns for 2026, with the stronger performance.